Matt TurnerPatient Affordability
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Suma Ramadas, PhDMedical Affairs
Pat PurcellMeeting Engagement
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Liz KaneImpactful Strategy
Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Daniel SontupeMarket Access
LAWRENCEVILLE, N.J., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology drug ...
The AVXS-101, now known as ZOLGENSMA® (onasemnogene abeparvovec-xxxx)[1], filing is supported by data from ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email